Eli Lilly Canada inc. v. Apotex Inc., 2010 FC 952 (Olanzapine*)
Justice Gauthier - 2010-09-24
Read full decision. Automatically generated summary:
In its motion made pursuant to Rule 399 of the Federal Courts Rules, SOR 98-106, Apotex Inc. (Apotex) asks the Court to set aside its order dated April 27, 2007, granting Eli Lilly Inc.'s (Eli) applications for an Order prohibiting the Minister of Health from issuing a Notice of Compliance (NOC) to Apotex for its olanzaprine products until the expiry of Canadian Letters Patent No. 2,041,113 ('113 patent). Apotex also seeks an order dismissing the said applications in the above-mentioned files.
Decision relates to:
- T-156-05 - ELI LILLY CANADA INC. v. APOTEX INC. ET AL
- A-400-10(2013 FCA 282) - which is an appeal from this decision
- T-787-05 - ELI LILLY CANADA INC. v. APOTEX INC. ET AL